Member Info for Mafuta

Celtic, good advice.

I have done the same, though at times it does get tempting to give as good as you get. Sometimes it's best not to justify their drivel by responding.

Looking forward in eager anticipation to getting a big fat juicy RNS sometime soon.

LH&K Mafuta.

Honestly some of the attempts to sow uncertainty of late have been utterly pathetic ... Hope they're not getting paid for it ... LH&K Mafuta

1a is testing MTD for healthy patients

LH&K Mafuta

"Trading in the first half of 2023 was strong and in line with the Board's expectations. Group revenues for the Period are expected to be approximately $14.1 million, representing a 19% increase from the prior year and setting a record high for the Group. Furthermore, this performance marks the sixth consecutive reporting period of growth for the Group. As a result, the Board remains confident that the Group is on track to meet its expectations for the full year."

Back in the black ... What's not to like?

LH&K Mafuta

Tissue Regenix (AIM: TRX), the regenerative medical device company, announces that it has signed an exclusive distribution agreement with Joint Operations Ltd ('Joint Operations'), a leading distribution business in the UK supplying numerous products to treat joint injuries and help to preserve the joints of the body, for the distribution of the Tissue Regenix OrthoPure® XT product in the United Kingdom.

Good news well done team. LH&K Mafuta

That's been posted on this BB of late ... Whether the CTA got rejected or not ... The CTA is underway in Australia and that's a cold hard FACT ... Honestly some are clutching at straws ... LH&K Mafuta

Interesting discussion but as Krone says that's all in the past ... We are currently in trials and that's all that matters ... We should be due news soon ... And guess what? ... It won't be coming from the MHRA ... LH&K Mafuta

"This is good news, very good news. Especially reporting on it whilst a trial is underway, hopefully subtle hints that all is ok."

... We are well into the trial and if there had been problems we would have been told ... And the trial would have been aborted ... No point in continuing at that stage ... In this case no news is really good news ... LH&K Mafuta

This is good news ... Could be a positive week ahead ... LH&K Mafuta

Https://twitter.com/sparksinsurrey?t=pdjO0xX-J-5LUqgCjq0ZJg&s=09

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for momelotinib by three months to provide time to review recently submitted data. The extended action date is 16 September 2023.

What are the FDA concerned about?

Really odd trading pattern today ... miniscule volume but a 7% rise ... strange to say the least (not complaining though ;o)

Shame it wasn't an open subscription 😞

This board has been unusually busy a few new faces too ... I somehow miss Mulder all of a sudden 🤣🤣

I reckon an update will be well possible. They should have something to share even if it's just "nobody has croaked it" LH&K Mafuta

Https://www.edisongroup.com/research/tyking-along-steadily-through-the-clinic/32395/

Https://twitter.com/Sareumplc/status/1666000065452711936?t=KHQGy2XMOWCaspHLb4blRw&s=19

Great news ... we have now moved from being a pre-clinical pharmaceutical to a clinical one ... That has to add value ... I don't quite understand why some are complaining about the wording of the RNS. Did they expect the BOD to enhance the truth or lie? ... We've had enough sad news on this BB lately so we can at least be happy when the good arrives. LH&K Mafuta

Great end to the week :0) Conference (Monday) and first dose (next week?) should see the momentum continue ... about time. Have a great weekend LH&K Mafuta

Monday 5th June 2023